Initial experience with long-acting risp
โ
Nicholas Keks; Cyril Been; Russell DโSouza; Rajan Thomas; Philip Tune; Jenny Ba
๐
Article
๐
2003
๐
Informa plc
๐
English
โ 82 KB
Objective: To report initial clinical experience with the injectable long-acting microspheres formulation of the atypical antipsychotic risperidone. Methods: Case reports. Results: The seven patients described have had good outcomes to date. A patient who has received the drug for 2 years has